GLP-1 boom poses a challenge for snack brands

Mounjaro Ozempic WeGovy GLP 1 GettyImages-2242381748

Source: Getty Images

Retailers and suppliers alike are scrambling to prepare for the proliferation of weight-loss drugs in the UK

Retailers and suppliers alike are scrambling to prepare for the proliferation of weight-loss drugs in the UK. GLP-1 users in the UK nearly doubled year on year by 2025 – from 2.3% to 4.1% – according to a Worldpanel by Numerator survey of nearly 12,000 UK households.

 

Already have an account? Sign in here

To read this valuable category report

Sign up to free guest access

Register now

Get access for £1 a week

Subscribe now